PerkinElmer Launches Industry First No-Wash Immunoassay For Phospho Ubiquitin Ser65 to Help Drive Neuroscience Disease and Therapeutics Research Forward
New kit provides highly sensitive and efficient approach for studying mitophagyimpairment in conditions such as Parkinson’s and Alzheimer’s WALTHAM, Mass. – October 26, 2020 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today launched the life science industry’s first no wash Ubiquitin phosphorylation at Serine 65 immunoassay for studying defective... Read more